, Tracking Stock Market Picks
Enter Symbol:
Arqule, Inc. (ARQL) [hlAlert]

up 27.23 %

Arqule, Inc. (ARQL) upgraded to Buy by UBS

Posted on: Tuesday,  Oct 13, 2009  8:25 AM ET by UBS

UBS rated Buy Arqule, Inc. (NASDAQ: ARQL) on 10/13/2009. Previously UBS rated Sell Arqule, Inc. (NASDAQ: ARQL) on 07/16/2009., when
the stock price was $5.56. Since then, Arqule, Inc. has lost 21.40% as of 10/13/2009's recent price of $4.37.
If you would have followed the previous UBS's recommendation on ARQL, you would have gained 27.23% of your investment in 89 days.

ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/13/2009 8:25 AM Buy
as of 12/31/2009
1 Week up  86.92 %
1 Month up  91.08 %
3 Months up  60.71 %
1 YTD up  85.24 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/16/2009 8:25 AM Sell
4/3/2009 8:25 AM Hold
1/29/2008 8:25 AM Buy
12/20/2007 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy